Sab Biotherapeutics (SABS) traded down -6.58 % during a 24 hours period ending at 12:20 AM Central Europe on Tuesday 27th. One Sab Biotherapeutics stock can currently be bought for about USD 2.79 on popular exchanges. Current supply of Sab Biotherapeutics stocks is 91 mn. Sab Biotherapeutics has a current market capitalization of USD 258.4 mn and approximately USD 2.9 mn worth of Sab Biotherapeutics was traded on exchanges in the last 24 hours. Since last month end, Sab Biotherapeutics has traded -15.22 % down. Simple moving average of last 200 days is at USD 3.7. The highest price of past 52 weeks was recorded at USD 5.15 on 03/12/2026. 52 weeks low was at USD 2.44 on 10/19/2026.
Here is how related stocks have performed in the past 24 hours:
Fvcbankcorp (FVCB) traded down -5.73 % and now trades at USD 17.03. Current market capitalisation for Fvcbankcorp is USD 308.4 mn. Current price/earnings ratio for Fvcbankcorp is 11.83.
Spring Valley Acquisitio (SVIV) traded down -0.1 % and now trades at USD 10.07. Spring Valley Acquisitio has a market capitalisation of USD 309.1 mn.
Vine Hill Capital Inves (VHCP) traded flat 0 % and now trades at USD 10.07. Vine Hill Capital Inves has a market capitalisation of USD 308.8 mn.
Nn (NNBR) traded down -0.9 % and now trades at USD 3.36. Current market capitalisation for Nn is USD 309.4 mn.
Ithax Acquisition (ITHA) traded down -0.4 % and now trades at USD 10.09. Ithax Acquisition has a market capitalisation of USD 308.8 mn.
About Sab Biotherapeutics
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company based in Sioux Falls, United States. The company’s mission is to harness the power of the body’s natural defense system to tackle the intricacies, rise, and mutations of human disease. They operate on Nasdaq and their website is www.sabbiotherapeutics.com .
